Serum intact parathyroid hormone levels predict hospitalisation for heart failure

Heart

Volumn 95, Issue 5, 2009, Pages 395-398

  Sugimoto, T ^a   Tanigawa, T ^a   Onishi, K ^b   Fujimoto, N ^b   Matsuda, A ^a   Nakamori, S ^a   Matsuoka, K ^a   Nakamura, T ^a   Koji, T ^a   Ito, M ^b  

^a Matsusaka Chuo Hospital   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PARATHYROID HORMONE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HORMONE DETERMINATION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PARATHYROID HORMONE BLOOD LEVEL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE;

EID: 61949315670     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.147652     Document Type: Article

References (28)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46.
3. Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002;23:877-85.
4. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
5. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16.
6. Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007;116:249-57.
7. Christ M, Thuerlimann A, Laule K, et al. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. Eur J Clin Invest 2007;37:834-41.
8. DiPette DJ, Christenson W, Nickols MA, et al. Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 1992;130:2045-51.
9. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1995;136:3024-30.
10. Hara M, Liu YM, Zhen L, et al. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 1997;96:3704-9.
11. Weber KT. The proinflammatory heart failure phenotype: a case of integrative physiology. Am J Med Sci 2005;330:219-26.
12. Sun Y, Ahokas RA, Bhattacharya SK, et al. Oxidative stress in aldosteronism. Cardiovasc Res 2006;71:300-9.
13. Alsafwah S, Laguardia SP, Arroyo M, et al. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 2007;5:238-43.
14. Khouzam RN, Dishmon DA, Farah V, et al. Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 2006;331:30-4.
15. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease - a review. Eur Heart J 2004;25:1776-87.
16. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-20.
17. Mallat Z, Philip I, Lebret M, et al. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998;97:1536-9.
18. Tang WH, Francis GS. The year in heart failure. J Am Coll Cardiol 2006;48:2575-83.
19. Felsenfeld AJ, Rodríguez M, Aguilera-Tejero E. Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism. Clin J Am Soc Nephrol 2007;2:1283-305.
20. Haller H, Lindschau C, Quass P, et al. Protein phosphorylation and intracellular free calcium in platelets of patients with essential hypertension. Am J Hypertens 1992;5:117-24.
21. Haller H, Bock A, Harwig S, et al. Effect of exogenous mineralocorticoid on platelet cytosolic calcium in normal humans. J Hum Hypertens 1995;9:249-54.
22. Arakelyan KP, Sahakyan YA, Hayrapetyan LR, et al. Calcium-regulating peptide hormones and blood electrolytic balance in chronic heart failure. Regul Pept 2007;142:95-100.
23. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207.
24. Maiya S, Sullivan I, Allgrove J, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008;94:581-4.
25. Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis-associated heart failure. Heart 2008;94:540-1.
26. Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35- 41.
27. Carlstedt F, Lind L, Wide L, et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 1997;27:977-81.
28. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality. The Hoorn Study. Kidney Int 2002;62:1402-7.